Agenus (AGEN) Depreciation & Amortization (CF) (2010 - 2026)

Agenus' (AGEN) quarterly Depreciation & Amortization (CF) came in at $583000.0 in Q1 2026, down 81.8% year-on-year from $3.2 million in Q1 2025, and down 2.35% quarter-over-quarter from $597000.0 in Q4 2025.

Agenus (AGEN) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Agenus' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $583000.0 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 81.8% year-over-year to $583000.0 in Q1 2026; TTM through Mar 2026 was $7.4 million, a 43.98% decrease from a year earlier, with the FY2025 full-year figure at $10.0 million, down 25.06% from the prior year.
  • Depreciation & Amortization (CF) eased to $583000.0 in Q1 2026 per AGEN's latest filing, from $597000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $5.2 million in Q4 2023 and bottomed at $583000.0 in Q1 2026.
  • The 5-year median for Depreciation & Amortization (CF) is $3.0 million (2023), against an average of $2.6 million.
  • Across the five-year window, Depreciation & Amortization (CF) jumped 175.33% in 2023 and slumped 81.8% in 2026, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $1.9 million in 2022, then soared by 175.33% to $5.2 million in 2023, then slumped by 37.32% to $3.3 million in 2024, then plunged by 81.69% to $597000.0 in 2025, then dropped by 2.35% to $583000.0 in 2026.
  • Per Business Quant, the three latest AGEN Depreciation & Amortization (CF) figures stand at $583000.0 (Q1 2026), $597000.0 (Q4 2025), and $3.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Agenus 184.05 Mn 177.29 Mn 33.74 Mn 583,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 583,000.00
Mar 31, 2026 583,000.00
Dec 31, 2025 597,000.00
Dec 31, 2025 597,000.00
Sep 30, 2025 3.03 Mn
Sep 30, 2025 3.03 Mn
Jun 30, 2025 3.17 Mn
Jun 30, 2025 3.17 Mn
Mar 31, 2025 3.20 Mn
Mar 31, 2025 3.20 Mn
Dec 31, 2024 3.26 Mn
Dec 31, 2024 3.26 Mn
Sep 30, 2024 3.35 Mn
Sep 30, 2024 3.35 Mn
Jun 30, 2024 3.36 Mn
Jun 30, 2024 3.36 Mn
Mar 31, 2024 3.37 Mn
Mar 31, 2024 3.37 Mn
Dec 31, 2023 5.20 Mn
Dec 31, 2023 5.20 Mn